Here are five points:
1. Europe follows North America, with the second largest global neurosurgery market share.
2. Asia Pacific will witness rapid market growth, due to advancing research and development activities as well as increasing government funding.
3. Advancing economies in India, China and Japan will boost market growth in Asia.
4. Neurosurgery equipment costliness, strict regulations and unfavorable reimbursements will pose as obstacles to market growth.
5. Medtronic, B. Braun Melsungen, Stryker, BrainLab, Integra LifeSciences, among others, lead the market.
More articles on devices:
SeaSpine launches the Hollywood VI NanoMetalene TLIF device: 5 points
Evolutionary vs. revolutionary: The future of surgical devices and spine surgery
Amendia launches Ceres-C cervical interbody device: 4 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
